Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/VTRS
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Viatris Inc (VTRS) Stock Price Today

OverviewTechnicalsFundamentalsFinancialsNewsCorp ActionAbout
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Viatris (VTRS) trades at $16.96, up 1.56% on the day and near its 52-week high of $17.53. The stock shows a bullish technical trend with consistent earnings beats in recent quarters. However, fundamentals reveal challenges, including a net loss of $3.51 billion in 2025 and negative profit margins, though revenue remains stable around $14.3 billion. Positive developments include a strong pipeline, with recent FDA acceptance of a new drug application for fast-acting meloxicam and positive Phase 3 results for VR-205.
The outlook is mixed; analyst consensus is a 'Hold' with a $20 price target, suggesting modest upside. Key opportunities lie in pipeline catalysts and debt reduction, but risks include persistent profitability issues, high debt levels, and competitive pressures. The stock's valuation metrics like P/S of 1.35 may appeal to value investors, but earnings sustainability is a concern.
Read full analysis

Key Stats

  • MARKET_CAP
    $19.56B
  • VOLUME
    -
  • SECTOR
    Health
  • FIFTY_TWO_WEEK_HIGH
    $17.39
  • FIFTY_TWO_WEEK_LOW
    $8.74
  • TYPICAL_HOLD_TIME
    -
  • ENTERPRISE_VALUE
    $31.77B
  • DIVIDEND_YIELD
    2.86%
  • TRADING_ACTIVITY
    -
$16.97
52W Low: $8.74
31 Jul 2025
52W High: $17.39
07 May 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $8.74 and a high of $17.39, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Most Recent News

Content is generated by Aura AI

Pepeto presale surpasses $10.41M as XRP whales shift focus amid XRP's $6 price forecast.

Pepeto's presale rapidly exceeded $10.41 million, attracting large XRP holders who see limited upside in XRP's predicted $6 price despite ongoing political hurdles. Pepeto's unique model, led by a former Binance executive, integrates token demand dir...

Market News
35 minutes ago
Unknown
Bullish
news icon
pluang ai news

Law firm investigates Oxford Industries for possible securities fraud after revenue guidance cut.

Pomerantz LLP is investigating Oxford Industries and some of its executives for potential securities fraud following the company's significant reduction in its 2026 revenue guidance and lower-than-expected Q2 sales projections. This announcement caus...

Market News
1 hour ago
Pomerantz Llp
Bearish
news icon
pluang ai news

Law firm investigates ON Semiconductor after stock drops 24% post Synaptics buyout news

Pomerantz LLP is investigating ON Semiconductor Corporation for potential securities fraud following its announcement to acquire Synaptics Incorporated in an all-stock deal valued at around $7 billion. The deal offers Synaptics shareholders 1.35 ON S...

Market News
1 hour ago
Pomerantz Llp
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

Key Stats

  • MARKET_CAP
    $19.56B
  • VOLUME
    -
  • SECTOR
    Health
  • FIFTY_TWO_WEEK_HIGH
    $17.39
  • FIFTY_TWO_WEEK_LOW
    $8.74
  • TYPICAL_HOLD_TIME
    -
  • ENTERPRISE_VALUE
    $31.77B
  • DIVIDEND_YIELD
    2.86%
  • TRADING_ACTIVITY
    -
$16.97
52W Low: $8.74
31 Jul 2025
52W High: $17.39
07 May 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $8.74 and a high of $17.39, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!